Increased Endothelin-1 and Vascular Endothelial Growth Factor Production Changes as an Indicator for Endothelial Dysfunction Associated With Antiphospholipid Syndrome Clinical Manifestations. This evidence concerns the gene VEGFA and antiphospholipid syndrome.